For the modern technology leader, the quest for peak performance has traditionally been a matter of chemistry, an endless ...

The journey towards circular high-performance composites begins with one core question: why redesign an already mature class ...

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real ...

Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.

Researchers use directed evolution to create magneto-sensitive fluorescent proteins that can interact with magnetic fields and radio waves ...

Pharmacelera has already participated in more than 100 projects to date, including several notable successes in GPCRs. It has won repeat business from customers in both Europe and the U.S., including ...

The Oklahoma State Department of Education announced the 10 finalists to the 2026 Teacher of the Year award.

Frost & Sullivan is pleased to announce that Bioiberica has received the 2025 European New Product Innovation Recognition in the ...

Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...

While the US remains the supreme destination, local biotechs and investors are scouring for untapped opportunities elsewhere. ... Read More The post Biocurious: from Türkiye to Tashkent, biotechs ...

Even in the best-case scenario, it’s incredibly disruptive. And this is where you’ve been quoted saying that A.I. will disrupt 50 percent of entry-level white-collar jobs. On a five-year time horizon, ...

People can sometimes come up with an idea that may seem absurd when you hear them bring it up. Yet, through some twist of ...